Neogen Chemicals QIP raises ₹600 crore at ₹2,255 price

What the QIP completion means for Neogen

Neogen Chemicals has completed a Qualified Institutions Placement (QIP), raising about ₹600 crore from eligible institutional investors. The company allotted 26,60,753 equity shares at an issue price of ₹2,255 per share, taking the gross issue size to ₹599.9998 crore (₹5,99,99,98,015). The fund-raising committee of the board approved the allotment at a meeting held on September 16, 2026. The placement widened the company’s institutional ownership mix and increased its equity base through a fresh issue of shares.

Pricing: premium to the regulatory floor

The final issue price of ₹2,255 per share was set above the regulatory floor price of ₹2,189.73. Neogen said the QIP was priced at a 2.98% premium to that floor. The equity shares have a face value of ₹10 each, and the issue price included a premium of ₹2,245 per share. The company also stated that the newly issued shares will be listed on both the BSE and NSE. These shares will rank pari passu with existing equity shares, including for dividend entitlement and voting rights.

Timeline: approvals and issue window

The QIP followed a set sequence of corporate and investor approvals. Neogen’s board approved the fund-raise on July 24, 2026. Shareholder approval was subsequently received through a special resolution passed on August 21, 2026. The QIP opened on September 10 and closed on September 16, 2026. The company’s exchange filing dated September 17, 2026, highlighted the completion of the issue and the allotment details.

Who participated: list of key institutional buyers

The QIP saw participation from several domestic mutual funds and large global investors. Names disclosed include ICICI Prudential Mutual Fund, Invesco Mutual Fund, Mirae Asset Mutual Fund, SBI Life Insurance Company, Whiteoak Capital Mutual Fund, Axis Mutual Fund and Abu Dhabi Investment Authority. The allocation data also listed investors who received more than 5% of the shares offered in the QIP. This mix indicates demand across mutual funds, insurance capital, and overseas institutional pools.

Share capital impact: paid-up capital rises to ₹30.04 crore

Following the allotment, Neogen’s paid-up equity share capital increased from ₹27.38 crore to ₹30.04 crore. The total number of equity shares rose to 3,00,42,427 from 2,73,81,674, based on the figures disclosed. The change reflects the issuance of 26,60,753 new equity shares under the placement. For existing shareholders, this is a fresh equity issuance that expands the overall share count while adding funds to the balance sheet.

Use of proceeds: debt, working capital, and corporate purposes

Neogen indicated that the net proceeds will be used for multiple purposes. The company listed repayment or pre-payment, in full or part, of certain borrowings as one of the intended uses. It also cited funding long-term working capital requirements and general corporate purposes. Separately, the article notes that proceeds are primarily earmarked for scaling battery materials projects and paring down existing debt. Taken together, the disclosed uses point to both balance-sheet management and funding for ongoing operational and project needs.

Market reaction: stock jumps after the announcement

Neogen Chemicals’ shares rose after the QIP completion was disclosed. The stock jumped 6.73% to ₹2,456.95 following the company’s announcement on the successful completion of the fund raise. Another intraday reference in the article said that at 10:22 am on September 17, 2026, the stock was trading at ₹2,369.60, up 2.94% from the previous close. These moves reflect the market’s immediate response to the concluded placement and the clarity on pricing and investor participation.

Key deal numbers at a glance

Allocation: investors with more than 5% of QIP shares

Why the QIP matters for investors tracking specialty chemicals

A QIP typically serves two purposes that investors watch closely: capital availability and investor mix. In Neogen’s case, the stated use of proceeds includes debt repayment or pre-payment, which can reduce finance costs and improve balance sheet metrics over time, depending on the quantum repaid. The company also flagged long-term working capital requirements, which is relevant for specialty chemical businesses where inventory cycles and raw material procurement can be capital intensive. The participation of multiple mutual funds, an insurance company, and a sovereign-backed investor also broadens the institutional shareholder base, which can influence liquidity and market visibility.

Conclusion

Neogen Chemicals’ ₹600 crore QIP, priced at ₹2,255 per share, closes a key fund-raising event for the company in September 2026. The issue increased paid-up capital to ₹30.04 crore and expanded the share count to 3,00,42,427 shares, with the new shares set to list on BSE and NSE on pari passu terms. The company has outlined debt-related actions, long-term working capital, and general corporate purposes as intended uses for the proceeds, with the article also pointing to battery materials project scaling. Investors will track subsequent disclosures on the pace of deployment of funds and any updates on borrowings and project execution.